ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Corgi All World 2x Daily ETF
23.82
-0.1769
-0.74%
盤後:
23.82
0.0000
0.00%
16:10 EDT
成交量:
147
成交額:
3,528
市值:
35.74萬
市盈率:
- -
高:
23.82
開:
23.70
低:
23.70
收:
24.00
52周最高:
25.58
52周最低:
20.48
股本:
1.50萬
流通股本:
1.50萬
量比:
0.64
換手率:
0.98%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
生物製品及CXO行業集體與投資者互動 企業「出海」進階 從產品輸出邁向能力輸出
证券日报
·
昨天
ETF日報:短期看在A股整體市場動能偏弱、熱點輪動加快的環境下,前期調整的創新藥、CXO板塊擁有一定性價比
新浪基金
·
09/14
中信建投:內外需改善逐步傳導訂單與業績 CXO有望進入新一輪增長階段
智通财经
·
09/14
【券商聚焦】中信證券:上半年CXO及生命科學上游板塊整體表現穩健,CRO有望量價齊升
金吾财讯
·
09/11
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/WX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","market":"US","secType":"STK","nameCN":"Corgi All World 2x Daily ETF","latestPrice":23.8247,"timestamp":1789588800000,"preClose":24.0016,"halted":0,"volume":147,"hourTrading":{"tag":"盘后","latestPrice":23.8247,"preClose":23.8247,"latestTime":"16:10 EDT","volume":6,"amount":142.698804,"timestamp":1789589404607,"change":0,"changeRate":0,"amplitude":0.005234},"delay":0,"changeRate":-0.007370341977201513,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"盤後交易","change":-0.1769,"latestTime":"09-16 16:32:35 EDT","open":23.7,"high":23.8247,"low":23.7,"amount":3528,"amplitude":0.005195,"askPrice":35.53,"askSize":200,"bidPrice":11.85,"bidSize":200,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"exchange":"CBOE","adjPreClose":24.0016,"nav":24.22,"aum":363300,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.8247,"preClose":23.8247,"latestTime":"16:10 EDT","volume":6,"amount":142.698804,"timestamp":1789589404607,"change":0,"changeRate":0,"amplitude":0.005234},"volumeRatio":0.644172},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.644172,"shares":15000,"dividePrice":0,"high":23.8247,"amplitude":0.005195,"preClose":24.0016,"low":23.7,"week52Low":20.48,"pbRate":"--","week52High":25.58,"institutionHeld":0,"latestPrice":23.8247,"eps":0,"divideRate":0,"volume":147,"delay":0,"ttmEps":0,"open":23.7,"prevYearClose":24.72,"prevWeekClose":24.6313,"prevMonthClose":24.9073,"prevQuarterClose":23.5672,"fiveDayClose":24.6388,"twentyDayClose":24.8296,"sixtyDayClose":23.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667218626","title":"生物製品及CXO行業集體與投資者互動 企業「出海」進階 從產品輸出邁向能力輸出","url":"https://stock-news.laohu8.com/highlight/detail?id=2667218626","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667218626?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 00:16","pubTimestamp":1789488960,"startTime":"0","endTime":"0","summary":"9月15日,科创板细分行业集体业绩说明会之生物制品及CXO(医药外包服务)行业集体业绩说明会召开,多家上市公司高管出席。从投资者互动的情况中可知,对于生物制品及CXO行业上市公司,关注的主要事项集中在“出海”、研发等方面。在互动过程中,相关公司高管进行了详细解答。在相关上市公司的半年报和互动过程中,“加大海外市场拓展力度”等信息被频繁提及。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609163875135164.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609163875135164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CXO","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667685646","title":"ETF日報:短期看在A股整體市場動能偏弱、熱點輪動加快的環境下,前期調整的創新藥、CXO板塊擁有一定性價比","url":"https://stock-news.laohu8.com/highlight/detail?id=2667685646","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667685646?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:02","pubTimestamp":1789383720,"startTime":"0","endTime":"0","summary":"形成赛道级利好共振,重塑市场对创新药研发进度与商业化价值的预期,修复创新药β行情,抬升CXO产业链订单与研发景气度预期。前期创新药、CXO板块经历持续回调,整体估值与市场情绪充分降温,板块点位回落至6-8月宽幅震荡箱体下沿位置,具备一定的技术性反弹空间。展望后市,短期看,在A股整体市场动能偏弱、热点轮动加快、反弹逐步收敛的环境下,前期调整的创新药、CXO板块拥有一定性价比。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-14/doc-iniruxuw4057482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["83130","02846","159982","BK1574","LNGR","03130","BK1147","BK4588","06978","BK4550","83188","MEDX","02827","FDN","399300","159992","BK4585","IBBQ","WX","03188","CXO","07233","82846","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667165628","title":"中信建投:內外需改善逐步傳導訂單與業績 CXO有望進入新一輪增長階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2667165628","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667165628?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:50","pubTimestamp":1789372227,"startTime":"0","endTime":"0","summary":"随着内外需改善逐步传导至订单与业绩,CXO有望进入新一轮增长阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["WX","CXO","BK0276","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666917512","title":"【券商聚焦】中信證券:上半年CXO及生命科學上游板塊整體表現穩健,CRO有望量價齊升","url":"https://stock-news.laohu8.com/highlight/detail?id=2666917512","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666917512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:07","pubTimestamp":1789088866,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指,2026年上半年,CXO板块及生命科学上游板块整体业绩表现稳健,行业进入复苏阶段。上半年海外投融资景气度持续,美联储加息预期走弱,早研板块整体的景气度持续走强,AIDD的快速发展也将进一步催化未来相关实验和验证需求的爆发,该机构认为CRO板块有望量价齐升。CDMO板块上半年龙头业绩表现稳健,整体订单增速持续加快,行业景气度回升。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","BK0028","LU1969619763.USD","LU0244354667.USD","03933","LU1997244956.HKD","02196","BK1500","LU0463099449.HKD","LU1146622755.USD","LU1794554557.SGD","LU2495084118.USD","CXO","BK0188","LU0348783233.USD","LU0540923850.HKD","LU1188198961.HKD","SG9999014674.SGD","SG9999004311.SGD","01099","LU2476274308.USD","02228","LU0561508036.HKD","BK1100","BK1521","LU0417516902.SGD","LU1997245177.USD","02268","BK1574","IE00B3M56506.USD","01530","09688","LU1997245094.SGD","LU2778985437.USD","06030","BK1593","KCE","09926","WX","BK0196","02367","LU0405327494.USD","600030","01789","06821","LU0634319403.HKD","LU2328871848.SGD","06160","LU1720050803.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/WX\",params:#limit:6,delay:false,,,undefined,":[]}}